DLD Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of DLD Antibodies for investigating DLD (Dihydrolipoamide Dehydrogenase) in various biological processes. DLD Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DLD is a crucial enzyme in the mitochondrial respiratory chain, playing a significant role in energy metabolism by facilitating the conversion of pyruvate and alpha-ketoglutarate into acetyl-CoA and succinyl-CoA, respectively. Proper DLD function is essential for maintaining cellular energy levels and metabolic homeostasis. Dysregulation of DLD has been implicated in various metabolic disorders and diseases, making it an important target for research. Researchers can effectively study energy metabolism pathways and their relationship to cellular function using specific DLD detection methods. Understanding DLD activity provides valuable insights into mitochondrial function and metabolic regulation. DLD research continues to reveal new connections between energy metabolism and disease progression. Santa Cruz Biotechnology monoclonal antibodies for DLD support researchers worldwide in advancing our understanding of metabolic processes and potential therapeutic approaches.